Off-label Use of Recombinant Activated Factor VII for Cardiac Surgical Bleeding

被引：4
|
作者：
Flynn, Brigid C. [1 ,4 ]
Steiner, Marie E. [2 ]
Mazzeffi, Michael [3 ]
机构：
[1] Univ Kansas, Dept Anesthesiol, Med Ctr, Kansas City, KS USA
[2] Univ Minnesota, Div Hematol Oncol & Crit Care, Minneapolis, MN USA
[3] Univ Virginia, Dept Anesthesiol, Sch Med, Charlottesville, VA USA
[4] Univ Kansas, Dept Anesthesiol, Med Ctr, Kansas City, KS 66160 USA
来源：
ANESTHESIOLOGY | 2023年 / 139卷 / 02期
关键词：
BLOOD-CELL TRANSFUSIONS; ACUTE AORTIC DISSECTION; INTRAOPERATIVE USE; DOUBLE-BLIND; SURGERY; SAFETY; NOVOSEVEN(R); MANAGEMENT; EFFICACY; RFVIIA;
D O I：
10.1097/ALN.0000000000004569
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
This review discusses the history and present-day off-label use of recombinant activated factor VII for cardiac surgical bleeding.
引用
收藏
页码：197 / 210
页数：14
相关论文
共 50 条
  • [41] Efficacy, Safety, and Strategies for Recombinant-Activated Factor VII in Cardiac Surgical Bleeding: A Narrative Review
    Kidd, Brent
    Sutherland, Lauren
    Jabaley, Craig S.
    Flynn, Brigid
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (04) : 1157 - 1168
  • [42] Recombinant activated factor VII for perioperative bleeding
    Lopez B, Rodrigo
    Aeschlimann D, Nicolas
    Carvajal F, Claudia
    Lema F, Guillermo
    [J]. REVISTA MEDICA DE CHILE, 2009, 137 (06) : 837 - 843
  • [43] Use of recombinant activated factor VII in patients with severe coagulopathy and bleeding
    Ho, AMH
    Dion, PW
    Karmakar, MK
    [J]. ANESTHESIOLOGY, 2003, 98 (04) : 1025 - 1026
  • [44] Management of bleeding emergencies: when to use recombinant activated Factor VII
    DeLoughery, TG
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (01) : 25 - 34
  • [45] Use of recombinant activated factor VII for bleeding in pancreatitis -: A case series
    Laffan, MA
    Tait, RC
    Blatny, J
    Espersen, K
    Grabowska, I
    Loch-Bakoñska, L
    Pauzkowska, A
    Stasiak-Pikula, E
    Michalska, G
    Wendon, J
    Piotrowska, K
    [J]. PANCREAS, 2005, 30 (03) : 279 - 284
  • [46] Use of recombinant activated factor VII for treatment and prophylaxis of major bleeding
    Henriques Vince, Flavio Augusto
    Nascimento Brandao, Maria Jose
    [J]. ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2009, 22 (03): : 171 - 178
  • [47] The use of recombinant activated factor VII in platelet-associated bleeding
    Franchini, Massimo
    Lippi, Giuseppe
    Guidi, Gian Cesare
    [J]. HEMATOLOGY, 2008, 13 (01) : 41 - 45
  • [48] Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7)
    Hacquard, Marie
    Durand, Marion
    Lecompte, Thomas
    Boini, Stephanie
    Briancon, Serge
    Carteaux, Jean-Pierre
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2011, 40 (06) : 1320 - 1327
  • [49] Off-label use of recombinant factor VIIa (rFVIIa) for postoperative hematuria in a factor VII deficient renal transplant patient.
    Gloster, E
    Strauss, R
    DaCosta, M
    Essex, D
    Distant, D
    Braverman, A
    [J]. BLOOD, 2000, 96 (11) : 82B - 83B
  • [50] Research on patient safety for off-label use of recombinant factor VIIa
    Aysola, Agnes E.
    Wahi, Monika M.
    McKelvey, Russell P.
    Gerdik, Cynthia Russell
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (08) : 600 - +
12345